Zhe Li

机构：China Pharmaceutical University, First Hospital of Shijiazhuang, Heze Municipal Hospital, First Affiliated Hospital of Zhengzhou University · ORCID：0000-0003-0493-8322

发表论文 304 篇 · 总被引 10271 次 · h-index 53

代表论文

• Targeting triple-negative breast cancer using cord-blood CD34⁺ HSPC-derived mesothelin-specific CAR-NKT cells with potent antitumor activity (2025 · Journal of Hematology & Oncology · 被引 20)
• Allogeneic stem cell-engineered EGFRvIII-specific CAR-NKT cells for treating glioblastoma with enhanced efficacy and safety (2025 · Molecular Therapy · 被引 18)
• Activating Ferroptosis of M1 Macrophages: A Novel Mechanism of Asiaticoside Encapsuled in GelMA for Anti‐Inflammation in Diabetic Wounds (2025 · Exploration · 被引 17)
• Multimodal targeting of metastatic renal cell carcinoma via CD70-directed allogeneic CAR-NKT cells (2025 · Cell Reports Medicine · 被引 15)
• Clinicopathological features and prognostic significance of site-specific metastasis in gastric cancer: a population-based, propensity score-matched analysis (2025 · Discover Oncology · 被引 7)
• Exploring the Potential of tsRNA as Biomarkers for Diagnosis and Treatment of Neurogenetic Disorders (2025 · Molecular Neurobiology · 被引 5)